Huntington’s Disease

Ongoing trials with importance for Huntington’s disease 4:24
Ongoing trials with importance for Huntington’s disease
Jee Bang • 4 Apr 2022
Targets in DNA repair machinery for the treatment of Huntington’s disease 2:26
Targets in DNA repair machinery for the treatment of Huntington’s disease
Jee Bang • 4 Apr 2022
How can we develop better DMTs in Huntington’s disease? 1:25
How can we develop better DMTs in Huntington’s disease?
Anne Rosser • 23 Sep 2021
A multidisciplinary approach to providing care in Huntington’s disease 3:28
A multidisciplinary approach to providing care in Huntington’s disease
Anne Rosser • 23 Sep 2021
Update: novel disease-modifying treatments in development for Huntington’s disease 2:20
Update: novel disease-modifying treatments in development for Huntington’s disease
Anne Rosser • 23 Sep 2021
Phase I trial of fetal striatal cell transplantation in Huntington’s disease 2:58
Phase I trial of fetal striatal cell transplantation in Huntington’s disease
Anne Rosser • 23 Sep 2021
Verbal skills and neurodegeneration 3:39
Verbal skills and neurodegeneration
Adolfo Garcia • 20 Sep 2021
RNA- and DNA- based therapies for neurodegenerative & neuromuscular diseases 13:42
RNA- and DNA- based therapies for neurodegenerative & neuromuscular diseases
Aida Abu-Baker • 11 Oct 2021
Gene-based therapies for neurodegenerative & neuromuscular diseases 3:23
Gene-based therapies for neurodegenerative & neuromuscular diseases
Aida Abu-Baker • 11 Oct 2021
Triheptanoin: targeting the Krebs cycle in Huntington’s disease 8:36
Triheptanoin: targeting the Krebs cycle in Huntington’s disease
Fanny Mochel • 24 Sep 2021
Manipulating protein quality control systems in neurodegenerative diseases: next steps 2:45
Manipulating protein quality control systems in neurodegenerative diseases: next steps
Anne Bertolotti • 30 Jul 2021
Increasing eIF2a phosphorylation to boost protein quality control in neurodegenerative disease 3:58
Increasing eIF2a phosphorylation to boost protein quality control in neurodegenerative disease
Anne Bertolotti • 30 Jul 2021
Protecting cells from misfolding stress to improve cell survival in neurodegenerative disease 6:14
Protecting cells from misfolding stress to improve cell survival in neurodegenerative disease
Anne Bertolotti • 30 Jul 2021
Emerging concepts: boosting protein quality control to treat neurodegenerative disease 4:21
Emerging concepts: boosting protein quality control to treat neurodegenerative disease
Anne Bertolotti • 30 Jul 2021
Therapies in the pipeline for Huntington’s disease 1:54
Therapies in the pipeline for Huntington’s disease
Anne Rosser • 18 Jun 2021
Cell therapy in Huntington’s disease: where are we now? 2:58
Cell therapy in Huntington’s disease: where are we now?
Anne Rosser • 18 Jun 2021
The content of VJNeurology is intended for healthcare professionals